ARTICLE | Clinical News
Triangle halts Coviracil enrollment
April 6, 2000 7:00 AM UTC
VIRS said it stopped enrolling additional patients in a South African study of its Coviracil emtricitabine nucleoside analog to treat HIV infection/AIDS. The company said there was a higher-than-expec...